1.
Richardson P, Htut M, Scott E, Prada CP, Gupta I. Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile. haematol [Internet]. 2025Feb.1 [cited 2025Feb.17];110(2):488-92. Available from: https://haematologica.org/article/view/haematol.2024.285380